, the Company’s customers had developed alternative sources of supplies of HRC and also imported large volumes of HRC. The import arrivals continued during the reported Quarter and impacted the sales
during the end of 2017 due to the Government Procurement and Supplies Management Act B.E. 2560 that is more stringent and resulted in government agencies becoming more cautious in spending. For domestic
2017 due to the Government Procurement and Supplies Management Act B.E. 2560 that is more stringent and resulted in government agencies becoming more cautious in spending. For domestic sectors
to the better control of selling unused materials and unused equipment. (4) Selling and Administrative Expenses Selling and administrative expenses for twelve months of year 2017 was 114.4 million Baht
. Analysis of Overall Operating Results for the Company and its subsidiary 1.1 Important circumstance during the year In April 2018, the Company acquired 800,000 ordinary shares of Aesthetic Zecret (AT-ZE
Thailand 1. Analysis of Overall Operating Results for the Company and its subsidiary 1.1 Important circumstance during the year In April 2018, the Company acquired 800,000 ordinary shares of Aesthetic Zecret
6.46 5.35 1.11 20.82 13.46 9.99 3.47 34.75 Drugs and medical supplies 0.11 0.24 (0.13) (54.12) 0.29 0.44 (0.15) (33.98) Other supplies 0.11 0.41 (0.29) (71.78) 0.34 0.58 (0.24) (41.55) X-ray 1.44 2.95
; primarily from decreasing in raw materials and medical supplies. The inventory turnover period was 5 days, remained the same as 2016. The Company and its subsidiaries recorded allowance for non-movement
. However, the Company does not require to seek approval from shareholders on this issue. 4. Total Asset and Investment Hospital building, medical equipment, medical supplies, in amount of Baht 133,583,482